Article Text

Download PDFPDF

002.5 Evaluation of five rapid point-of-care tests for syphilis: two treponemal only, and three dual treponemal/hiv assays
  1. Y Fakile1,
  2. K Hoover1,
  3. K Delaney1,
  4. L Wesolowski1,
  5. C Asef1,
  6. Y Sun1,
  7. I Park2,
  8. J Chow2,
  9. J Schapiro3,
  10. S Novak4,
  11. S Philip5,
  12. K Karem1
  1. 1Centers for Disease Control and Prevention
  2. 2California Department of Public Health
  3. 3The Permanente Medical Group Northern California Regional Laboratory
  4. 5San Francisco Department of Public Health
  5. 4Southern California Permanente Medical Group Regional Laboratory


Background Traditional syphilis and HIV screening strategies require laboratory capacity which is often limited in resource-poor settings. Affordable rapid point-of-care tests (RPOCT) with high sensitivity and specificity would allow same-day testing and referral for treatment of syphilis and HIV in pregnant women. This would allow a decrease in adverse outcomes as a result of mother-to-child transmission (MTCT). We compared test performance of two RPOCT treponemal tests and three combination treponemal/HIV tests for detection of treponemal antibodies in sera; and we also examined test performance of the three RPOCT treponemal/HIV tests for detection of HIV antibodies in sera.

 Methods We tested banked sera previously characterised for syphilis (n = 1186), from San Francisco Department of Public Health, Kaiser Permanente Northern and Southern California, and 437 known HIV-positive samples (CDC HIV), according to manufacturer’s insert with 3 dual HIV/Syphilis RPOCT: SD BIOLINE HIV Syphilis Duo (Standard Diagnostics), Multiplo TP/HIV (MedMira) and DPP HIV-syphilis Assay (Chembio), and 2 treponemal-only tests: SD Syphilis 3.0 (Standard Diagnostics), Determine SyphilisTP (Alere). Positive agreement across tests was determined and RPOCT results were compared to prior test results.

Results The 5 assays had concordant positive result of 84% (1362/1623) for treponemal antibodies, and 96.6% (1569/1623) for HIV antibodies. Compared to previously reported results, treponemal tests had sensitivities and specificities of; SD 3.0 – 72%, 97.2%; SD DUO- 72.2%, 97.2%; Multiplo- 80.7%, 88.7%; Chembio – 82.5%, 96.4%; DetermineTP- 89.3%, 97.5%. The 3 treponemal/HIV assays sensitivity was100% for 437 known HIV-positives compared to standard assays.

Conclusion Positive agreement was greater for HIV antibodies than for treponemal antibodies; Using banked sera could have affected performance of treponemal assays. Further prospective studies need to be performed in the field to better characterise performance of RPOCT treponemal tests. Findings from this study will provide data to guide countries’ selection of RPOCTs for syphilis and HIV screening.

Disclosure of interest statement The reagents/kits for this study, were donated by the various manufacturers (Standard Diagnostics, MedMira, Chembio, and Alere).

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.